Clinical Trials Sponsored by InterMune

Total 36 results

InterMune

Terminated

The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis | Pulmonary Fibrosis | Lung Disease

United States
InterMune

Completed

Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis

HIV Infections | Meningitis, Cryptococcal

United States, Peru
InterMune

Terminated

An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF

Idiopathic Pulmonary Fibrosis | Pulmonary Fibrosis | Lung Disease

United States
InterMune

Completed

Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis

Osteopetrosis

United States
InterMune

Terminated

Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection

Lung Infection
InterMune

Completed

CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)

Chronic Hepatitis C

United States
InterMune

Completed

A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United States
InterMune

Terminated

A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone

Pulmonary Fibrosis | Lung Disease

Italy
InterMune

Completed

Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis

Cirrhosis | Liver Fibrosis
InterMune

Terminated

Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer

Peritoneal Carcinoma | Ovarian Carcinoma

United States
InterMune

Completed

An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Pulmonary Fibrosis | Lung Disease

United States
InterMune

Completed

A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

United States
InterMune

Terminated

Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients

Non-Hodgkin's Lymphoma

United States
InterMune

Completed

Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis

Cystic Fibrosis

United States
InterMune

Completed

Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis

Cystic Fibrosis
University of East Anglia
InterMune

Unknown

Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis

Depression | Anxiety | Idiopathic Pulmonary Fibrosis | Dyspnoea

United Kingdom
Intervene, Inc.

Recruiting

Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-OUS)

Chronic Venous Insufficiency

New Zealand, Australia, Canada
Intervene, Inc.

Terminated

Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System - INFINITE-US (INFINITE-US)

Chronic Venous Insufficiency (CVI) | Deep Vein Reflux

United States
Intervene, Inc.

Withdrawn

Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System-Canada

Chronic Venous Insufficiency
Intervene, Inc.

Terminated

A Feasibility Study of the ReLeaf Catheter System (ReLeaf)

Chronic Venous Insufficiency

New Zealand
Brooke Army Medical Center
InterMune

Completed

Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

Hepatitis C

United States
Huntington Medical Research Institutes
InterMune

Unknown

A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B

Hepatitis B

United States
Beth Israel Medical Center
InterMune

Completed

Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

Hepatitis C

United States
Hoffmann-La Roche
InterMune Deutschland GmbH

Completed

Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)

Idiopathic Pulmonary Fibrosis

Germany
Accelerated Community Oncology Research Network
InterMune

Completed

Study of Gamma Interfereon in Metastatic Colorectal Carcinoma (GFL)

Colorectal Cancer

United States
Intervene Immune, Inc.

Recruiting

Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial (TRIIM-X)

Immunosenescence | Epigenetic Aging

United States
Association pour la Recherche en Medecine Interne

Not yet recruiting

Prevalence of Acute Hepatic Porphyria (PHA)

Acute Hepatic Porphyria
Cabinet de Medecine Interne Générale Demetrio Pitarch

Completed

Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk

Atherosclerosis of Artery
French National Agency for Research on AIDS and...
Hoffmann-La Roche; InterMune

Completed

Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C

Hepatitis C, Chronic

France
M.D. Anderson Cancer Center
Bristol-Myers Squibb; InterMune; Bayer Healthcare Pharmaceuticals, Inc./Bayer...

Completed

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States
Association Pour le Recherche en Infectiologie...
Pr Bruno Fantin

Completed

Epidemiology of Fluoroquinolone Resistance in Human Commensal Flora in Patients Hospitalised in Medical Wards

Colonization | Hospitalized Patients | Multi Drug Resistant Bacteria

France
University Hospital, Lille
Association pour la Formation et la Recherche en Médecine Interne (AFORMI)

Recruiting

Prevalence of Hyperprolactinemia in Systemic Scleroderma (SCLERO-PRL)

Scleroderma | Hyperprolactinemia | Sclerosis, Systemic

France
Minneapolis Veterans Affairs Medical Center
US Department of Veterans Affairs; Kadmon Corporation, LLC; InterMune; San Diego... and other collaborators

Completed

Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial

Chronic Hepatitis C
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Sorbonne... and other collaborators

Not yet recruiting

Clonal Hematopoiesis of Immunological Significance (CHIS)

Immune System Diseases | Lymphoma | Lymphoproliferative Disorders | Autoimmune Diseases | Inflammation | Myelodysplastic Syndromes | Hematologic Diseases | Leukemia | Myeloproliferative Disorders | Myelodysplastic-Myeloproliferative Diseases | Monoclonal Gammopathy of Undetermined Significance | Autoinflammatory... and other conditions
Université NAZI BONI
Juvenile Diabetes Research Foundation; International Society for Pediatric... and other collaborators

Recruiting

Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin

Type 1 Diabetes

Burkina Faso
University Hospital, Clermont-Ferrand
Institut Pascal (CNRS 6602/ Université Clermont Auvergne / SIGMA), équipe... and other collaborators

Recruiting

Design of an Augmented Reality System by Integration of CT Scan or MRI Data With Endoscopic Images for Video-assisted Endonasal Endoscopic Surgery (NORA)

Paranasal Sinus Diseases | Lacrimal Apparatus Diseases | Nasal Diseases

France

Clinical Trials Sponsored by InterMune

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations